- Home
- MEIP vs GORV Comparison
MEIP vs GORV Comparison
Compare MEIP & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEIP
- GORV
- Stock Information
- Founded
- MEIP 2000
- GORV 1976
- Country
- MEIP United States
- GORV United States
- Employees
- MEIP N/A
- GORV N/A
- Industry
- MEIP Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- MEIP Health Care
- GORV Consumer Discretionary
- Exchange
- MEIP Nasdaq
- GORV Nasdaq
- Market Cap
- MEIP 19.5M
- GORV 16.2M
- IPO Year
- MEIP 2003
- GORV 2015
- Fundamental
- Price
- MEIP $2.78
- GORV $1.02
- Analyst Decision
- MEIP Hold
- GORV Hold
- Analyst Count
- MEIP 2
- GORV 2
- Target Price
- MEIP $7.00
- GORV $2.00
- AVG Volume (30 Days)
- MEIP 53.1K
- GORV 871.0K
- Earning Date
- MEIP 11-12-2024
- GORV 11-18-2024
- Dividend Yield
- MEIP N/A
- GORV N/A
- EPS Growth
- MEIP N/A
- GORV N/A
- EPS
- MEIP N/A
- GORV N/A
- Revenue
- MEIP N/A
- GORV $920,774,000.00
- Revenue This Year
- MEIP N/A
- GORV N/A
- Revenue Next Year
- MEIP $300.00
- GORV $6.13
- P/E Ratio
- MEIP N/A
- GORV N/A
- Revenue Growth
- MEIP 33.76
- GORV N/A
- 52 Week Low
- MEIP $2.61
- GORV $0.79
- 52 Week High
- MEIP $6.91
- GORV $8.15
- Technical
- Relative Strength Index (RSI)
- MEIP 36.75
- GORV 44.56
- Support Level
- MEIP $2.76
- GORV $0.80
- Resistance Level
- MEIP $2.91
- GORV $1.96
- Average True Range (ATR)
- MEIP 0.11
- GORV 0.25
- MACD
- MEIP -0.04
- GORV 0.00
- Stochastic Oscillator
- MEIP 5.13
- GORV 19.59
About MEIP MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.